Needling issues: Syringe controversy reaches CGF court

Image
Press Trust of India Gold Coast
Last Updated : Apr 03 2018 | 10:30 AM IST

The needle controversy that has marred India's build-up to the Commonwealth Games has reached the doorsteps of the Commonwealth Games Federation (CGF) court which is hearing the matter, specifically cleared of any doping violation.

"The CGF Medical Commission has concluded its investigation into the alleged violation. They have escalated the matter to the CGF court. Following the hearing a decision will be made. Please wait till the final hearing. We will provide full overview of what happens," CGF CEO David Grevemberg said in his daily media briefing this morning.

"For clarification, this matter is not defined as an anti-doping rule violation, but rather as an infringement of the CGF's No Needle Policy, which has been introduced by major events organisers to ensure best medical practices," he added.

The CGF has stoically refused to name the national association or the athlete involved in the controversy which flared up after syringes were discovered at the Games Village on Saturday.

Speculation is rife that the country involved is India with a top official of the contingent yesterday confirming to PTI that syringe was used to inject multi-vitamins into a fatigued athlete.

The dope tests that followed the discovery of syringes have been negative, giving the concerned association, presumably India, massive relief.

However, sanctions such as a warning or fine could be placed by the CGF court for violating the no needle policy of the Games.

"The CGF court has the powers to put sanctions on individuals and federations. It looks at the impact of the violation. It will take an assessment of the evidence presented by the medical commission and then take appropriate action. I don't want to pre-empt what action it might take. We will continue to be vigilant," said Grevemberg.

The CGF's No Needle Policy is relaxed only for athletes requiring prescribed medication or nutritional supplements under the supervision of a medical practitioner.

However, the CGF insists that athletes should take prior permissions, failing which can result in unspecified sanctions.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 03 2018 | 10:30 AM IST

Next Story